National Institute of Neurological Disorders and Stroke; Notice of Meeting, 42969 [2013-17188]

Download as PDF Federal Register / Vol. 78, No. 138 / Thursday, July 18, 2013 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 12, 2013. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2013–17187 Filed 7–17–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meeting TKELLEY on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee (MDCC). The meeting will be open to the public and accessible by live webcast. Name of Committee: Muscular Dystrophy Coordinating Committee. Type of Meeting: Open Meeting. Date: August 26, 2013. Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*—Approximate end time. Agenda: The purpose of this meeting is to bring together the committee members to update one another on individual agency efforts, to discuss planning for revision of the Action Plan for the Muscular Dystrophies, and to discuss two issues affecting all types of muscular dystrophy: (a) Transitions to adulthood, career, and independence for individuals with muscular dystrophy and (b) therapeutic misconception in clinical trials. An agenda is posted to the MDCC Web site: https://www.ninds.nih.gov/find_people/ groups/mdcc/index.htm. Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/ 2013_MDCC_Meeting/. Webcast Live: For those not able to attend in person, this meeting will be webcast at: https://videocast.nih.gov/. Place: Neuroscience Center, 6001 Executive Boulevard, Conference Room A1/ A2, Rockville, Maryland 20852–1699. Contact Person: John D. Porter, Ph.D., Executive Secretary, Muscular Dystrophy Coordinating Committee, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, NSC 2172, Bethesda, MD 20892, (301) 496–5739, porterjo@ninds.nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the VerDate Mar<15>2010 17:20 Jul 17, 2013 Jkt 229001 organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Attendance is limited to seating space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed below in advance of the meeting. All visitors must go through a security check at the Lobby of the Neuroscience Center (NSC) building to receive a visitor’s badge. A government issued photo ID is required. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: July 11, 2013. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–17188 Filed 7–17–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel;, Molecular and Cellular Neuroscience. Date: July 29, 2013. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 42969 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Richard D Crosland, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4158, MSC 7850, Bethesda, MD 20892, 301–435– 1220, rc218u@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Genetics of Cell Regulation. Date: August 1, 2013. Time: 2:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 20892, 301–435– 1779, riverase@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Continuous Submission Panel. Date: August 6, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Mike Radtke, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4176, MSC 7806, Bethesda, MD 20892, 301–435– 1728, radtkem@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Shared Instrumentation: PET/CT/SPECT. Date: August 6, 2013. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Malgorzata Klosek, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4188, MSC 7849, Bethesda, MD 20892, (301) 435– 2211, klosekm@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: July 11, 2013. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–17190 Filed 7–17–13; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\18JYN1.SGM 18JYN1

Agencies

[Federal Register Volume 78, Number 138 (Thursday, July 18, 2013)]
[Notices]
[Page 42969]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17188]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Muscular Dystrophy Coordinating Committee (MDCC).
    The meeting will be open to the public and accessible by live 
webcast.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Type of Meeting: Open Meeting.
    Date: August 26, 2013.
    Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end 
time.
    Agenda: The purpose of this meeting is to bring together the 
committee members to update one another on individual agency 
efforts, to discuss planning for revision of the Action Plan for the 
Muscular Dystrophies, and to discuss two issues affecting all types 
of muscular dystrophy: (a) Transitions to adulthood, career, and 
independence for individuals with muscular dystrophy and (b) 
therapeutic misconception in clinical trials.
    An agenda is posted to the MDCC Web site: https://www.ninds.nih.gov/find_people/groups/mdcc/index.htm.
    Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/2013_MDCC_Meeting/.
    Webcast Live: For those not able to attend in person, this 
meeting will be webcast at: https://videocast.nih.gov/.
    Place: Neuroscience Center, 6001 Executive Boulevard, Conference 
Room A1/A2, Rockville, Maryland 20852-1699.
    Contact Person: John D. Porter, Ph.D., Executive Secretary, 
Muscular Dystrophy Coordinating Committee, National Institute of 
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, 
NSC 2172, Bethesda, MD 20892, (301) 496-5739, 
porterjo@ninds.nih.gov.

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Attendance is limited to seating space available. Individuals 
who plan to attend and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
inform the Contact Person listed below in advance of the meeting.
    All visitors must go through a security check at the Lobby of 
the Neuroscience Center (NSC) building to receive a visitor's badge. 
A government issued photo ID is required.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: July 11, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-17188 Filed 7-17-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.